Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling PathwaysGenhong Li(Fujian Medical University), Bing Xu(Fujian Medical University)Drugs in R&DOctober 17, 202310.1007/s40268-023-00442-6Cited by 7SaveCiteExport RISWatch citationsRelated PapersCombination of HDAC inhibitor and PI3K inhibitor suppresses autophagy and induces apoptosis via cytoplasmic IκBα stabilization in p53-mutant diffuse large B-cell lymphoma|Cell Death Discovery|2025|1Anlotinib Induced Venetoclax-resistant Acute Myeloid Leukemia Stem Cells Apoptosis through Downregulating Mcl-1-mediated Anti-apoptoeic Pathway|Research Square|2025|0